D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
PUT
Medtronic
MDT
$111B
| $1.77M | ﹤0.01% |
15,000
-71,500
| -83% | -$8.38M |
|
2552
PUT
Olin
OLN
$2.44B
| $1.77M | ﹤0.01% |
+46,600
| New | +$1.41M |
|
2553
Century Communities
CCS
$2.05B
| $1.77M | ﹤0.01% |
+29,311
| New | +$1.59M |
|
2554
PUT
Tandem Diabetes Care
TNDM
$1.22B
| $1.76M | ﹤0.01% |
+20,000
| New | +$1.86M |
|
2555
PUT
CarMax
KMX
$8.36B
| $1.76M | ﹤0.01% |
13,300
-14,700
| -53% | -$1.79M |
|
|
JOBS
2556
DELISTED
51job Inc
JOBS
| $1.76M | ﹤0.01% |
28,184
+10,832
| +62% | +$723K |
|
2557
Nabors Industries
NBR
$1.12B
| $1.76M | ﹤0.01% |
18,856
+7,818
| +71% | +$697K |
|
2558
Covenant Logistics
CVLG
$1.09B
| $1.76M | ﹤0.01% |
170,924
-15,360
| -8% | -$137K |
|
2559
CALL
Dillards
DDS
$9.2B
| $1.76M | ﹤0.01% |
18,200
+500
| +3% | +$40.6K |
|
2560
Insperity
NSP
$2.01B
| $1.76M | ﹤0.01% |
20,990
+3,506
| +20% | +$298K |
|
2561
CALL
State Street
STT
$50.2B
| $1.76M | ﹤0.01% |
20,900
-15,700
| -43% | -$1.22M |
|
2562
PUT
Invesco Mortgage Capital
IVR
$769M
| $1.75M | ﹤0.01% |
43,760
-2,740
| -6% | -$103K |
|
2563
Seagate
STX
$169B
| $1.75M | ﹤0.01% |
22,861
-129,209
| -85% | -$8.99M |
|
2564
PUT
Cinemark Holdings
CNK
$4.09B
| $1.75M | ﹤0.01% |
+85,800
| New | +$1.81M |
|
|
LGACU
2565
DELISTED
Lazard Growth Acquisition Corp. I Units
LGACU
| $1.75M | ﹤0.01% |
+175,000
| New | +$1.78M |
|
2566
PUT
ZTO Express
ZTO
$18.2B
| $1.75M | ﹤0.01% |
60,000
-11,900
| -17% | -$388K |
|
|
STFC
2567
DELISTED
State Auto Financial Corp
STFC
| $1.75M | ﹤0.01% |
88,705
-8,803
| -9% | -$162K |
|
|
CAS
2568
DELISTED
Cascade Acquisition Corp.
CAS
| $1.75M | ﹤0.01% |
+178,281
| New | +$1.81M |
|
2569
PUT
Jack Henry & Associates
JKHY
$11.2B
| $1.75M | ﹤0.01% |
+11,500
| New | +$1.75M |
|
|
AVAN
2570
DELISTED
Avanti Acquisition Corp.
AVAN
| $1.75M | ﹤0.01% |
+178,560
| New | +$1.85M |
|
|
HONE
2571
DELISTED
HarborOne Bancorp
HONE
| $1.74M | ﹤0.01% |
129,313
+36,443
| +39% | +$443K |
|
2572
Atea Pharmaceuticals
AVIR
$361M
| $1.74M | ﹤0.01% |
+28,187
| New | +$1.9M |
|
|
TLND
2573
DELISTED
Talend S.A. American Depositary Shares
TLND
| $1.74M | ﹤0.01% |
+27,323
| New | +$1.42M |
|
|
CMRC
2574
CALL
Commerce.com Inc Series 1
CMRC
$264M
| $1.73M | ﹤0.01% |
+30,000
| New | +$1.99M |
|
|
SEAH
2575
DELISTED
Sports Entertainment Acquisition Corp.
SEAH
| $1.73M | ﹤0.01% |
+177,318
| New | +$1.81M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.